US Global Jets ETF vs Personalis Inc. Common Stock — how do they compare? US Global Jets ETF trades at $25.81 (market cap $812.53M), while Personalis Inc. Common Stock trades at $16.14 (market cap $1.69B). The key difference: Personalis Inc. Common Stock is far larger — about 2.1× US Global Jets ETF's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold US Global Jets ETF for 27 Days and Personalis Inc. Common Stock for 0 Days on average.
| JETS | PSNL | |
|---|---|---|
Market Cap | $812.53M | $1.69B |
Volume | 5,144,947 | 3,817,236 |
Sector | Sector/Thematic | Health |
52-Week High | $33.53 | $18.38 |
52-Week Low | $23.64 | $5.04 |
Typical Hold Time | 27 Days | 0 Days |
Enterprise Value | — | $1.52B |
Signals from Pluang's Aura AI — not financial advice
JETS is trading at $26.80, down 0.81% with a bearish technical outlook indicated by moving averages. The ETF faces headwinds from rising fuel costs and geopolitical tensions, though strong travel demand provides some support. Recent news highlights underperformance compared to aerospace/defense ETFs, with fuel expenses surging 85% in May 2026 according to Reuters.
The outlook remains cautious due to fuel price volatility and competitive pressure from alternative aviation ETFs. Near-term performance depends on fuel cost management and travel demand sustainability, with technical support at $26 providing a key level to watch.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →